Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Tomohiro Kaneko Added: 6 months ago
EuroPCR 25 - Real-world registry findings show transcatheter edge-to-edge repair (TEER) is associated with improved prognosis in patients with atrial functional mitral regurgitation (AFMR).We are joined by Dr Tomohiro Kaneko (Juntendo University Graduate School of Medicine, Tokyo, JP) to discuss outcomes from a retrospective cohort study analysing data from two large-scale Japanese registries,… View more
Author(s): Safia Chatur Added: 6 months ago
ESC HF 25 - In a FINEARTS HF post-hoc analysis, the relative and absolute effects of finerenone relative to placebo did not significantly differ across kidney function.We are joined by Dr Safia Chatur (Mass General Cardiology, US) to discuss key findings from the FINEARTS-HF trial. This Phase 3 study evaluated the effect of finerenone versus placebo on cardiovascular death and total heart failure… View more
Author(s): Nicolas Girerd Added: 6 months ago
ESC HF 25 - Real-world findings suggest kidney function decline could precede heart failure events by up to a year.Prof Nicolas Girerd (University Hospital of Nancy, Nancy, FR) discusses real-world findings from pooled trials EPHESUS, EMPHASIS-HF and BARCELONA. The study investigated if longitudinal changes in kidney function could help identify patients with HFrEF at a higher risk of… View more
Author(s): Mikhail Kosiborod Added: 1 year ago
HFSA 24 - We are joined virtually by Dr Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, US) to discuss findings from the STEP-HFpEF trial programme in regard to the efficacy of semaglutide according to frailty status, and exercise function at baseline.Interview Questions:1. Could you remind us of the importance of STEP-HFpEF2. What was the study design and patient population?3. What… View more
Author(s): P Kasi Ramanathan Added: 1 month ago
TCT 2025 - Sub-anlysis findings showed positive safety and efficacy outcomes of the PASCAL Precision system in degenerative mitral regurgitation (DMR) patients.Dr P Kasi Ramanathan (Promedica Toledo Hospital, US) joins us on-site at TCT 2025 to share the findings from a sub-analysis looking at the affect of implant location and leaflet lesion location on the safety and effectiveness of the PASCAL… View more
Added: 4 months ago Source:  Radcliffe Cardiology
The classification and risk stratification of aortic, mitral, and tricuspid regurgitation present significant clinical challenges, with diagnosis often subject to interobserver variability. The DELINEATE-Regurgitation study investigated a novel artificial intelligence (AI) system designed to provide accurate, reproducible echocardiographic assessment of valvular regurgitation and to stratify the… View more
Author(s): Firas Zahr Added: 1 year ago
TCT Conference 24 - Two-year outcomes of CLASP IID shows that the Edwards PASCAL system was noninferior to the Abbott Mitraclip system in transcatheter mitral valve repair for mitral regurgitation.Dr Firas Zahr (Oregon Health and Science University, US) joins us onsite at TCT Conference to discuss the outcomes from the CLASP IID 2 Year RCT and Registry (NCT02371512; Edwards Lifesciences).CLASP… View more
Author(s): Stephan Baldus Added: 1 year ago
TCT Conference 2024 - Clinical outcomes between percutaneous mitral valve repair (PMVR) and mitral valve surgery in patients with atrial mitral regurgitation (MR).Dr Stephan Baldus (University of Köln Medical Center, DE) joins us onsite at TCT Conference to discuss the findings from MATTERHORN (NCT02371512; University of Köln).MATTERHORN is a multicenter, randomized controlled clinical trial,… View more